Incumbent 发表于 2025-3-30 11:34:32
Patient Navigation of the Pediatric Bone Tumor Patient Across the Continuum of Care,their multiple treatment plans their child will face. The oncology nurse navigator (ONN) plays a vital role in caring for and navigating the bone tumor patient and their family from the very onset of diagnosis through the continuum of care. The Oncology Nurse Navigator serves as a single point of coCircumscribe 发表于 2025-3-30 13:38:51
http://reply.papertrans.cn/63/6220/621981/621981_52.png协奏曲 发表于 2025-3-30 16:45:04
http://reply.papertrans.cn/63/6220/621981/621981_53.pngcalamity 发表于 2025-3-30 21:27:35
Recurrent Bone Tumors,ive therapies and incorporation of novel agents in trials, the therapeutic plateau in recurrent osteosarcoma and Ewing sarcoma has not yet been overcome. Cure for these patients remain a daunting challenge with dismal survival rate after relapse despite best efforts. Certain clinical factors help prCROW 发表于 2025-3-31 02:56:06
Novel Therapies on the Horizon, substantial fraction of patients who are not cured by current therapies. In addition, even those who are long term survivors often suffer chronic side effects of treatment. Thus, we need to continue to explore novel therapies both to increase the cure rates and decrease complications. In this chaptmicturition 发表于 2025-3-31 05:23:22
http://reply.papertrans.cn/63/6220/621981/621981_56.png北极熊 发表于 2025-3-31 09:16:41
Fertility Preservation and Reproductive Health in Pediatric Bone Tumor Patients,ity on fertility and report high levels of psychological distress associated with fertility loss. Options are available to preserve fertility prior to chemotherapy when possible, but multiple barriers exist which reduce the likelihood of fertility preservation utilization.Instrumental 发表于 2025-3-31 15:06:42
Post-therapy Surveillance of Bone Tumors,ut forth consensus guidelines for surveillance. This chapter aims to discuss the rationale, utility and standard recommendations for surveillance post chemotherapy for those with pediatric bone tumors.